Navigation Links
Breast Imaging Company, TechniScan, Signs Manufacturing Agreement With Texas Company
Date:2/24/2011

SALT LAKE CITY, Feb. 24, 2011 /PRNewswire/ -- TechniScan (OTC Bulletin Board: TSNI), a medical device company engaged in the development and commercialization of an automated 3D breast ultrasound imaging system, announced today that it has signed agreements for manufacturing and use of trademarks with Austin, Texas-based Womens3D.

These agreements follow a product development agreement signed between the two companies in January 2011 in which they agreed to jointly develop a specialized version of TechniScan's Warm Bath Ultrasound (WBU) system specifically for Womens3D target market of women's specific health practices such as OB/GYN and general practice offices.

Under the terms of the manufacturing agreement, TechniScan will be the exclusive manufacturer and supplier of the product(s) and Womens3D will receive a license to sell the product to its target market. The license becomes exclusive upon certain conditions being met, including payment of at least $1.5 million to TechniScan in connection with the initial design and development of the product. Womens3D has also committed to purchase at least $10 million of TechniScan's products during the 36 months following FDA approval.

In addition to the manufacturing and trademark agreements, TechniScan receives shares of Womens3D common stock equal to 20 percent of the current capitalization of Womens3D.

"TechniScan is energized by our new partnership with Womens3D. We are looking forward to collaborating on the development and manufacturing of a WBU imaging system that addresses the unique needs of their target market. The partnership will potentially open new markets for our equipment and add an experienced medical imaging partner to our development efforts," said Dave Robinson, chief executive officer of TechniScan. 

Womens3D's Chief Medical Officer and Research Scientist and Imagin
'/>"/>

SOURCE TechniScan
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
3. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
4. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
5. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
6. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
7. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
8. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
9. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
10. Spit for the Cure Offers Unique Opportunity for Women to Participate in Breast Cancer Research
11. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... PAUL, Minn. , July 29, 2014  EnteroMedics ... medical devices using neuroblocking technology to treat obesity, metabolic ... will host a conference call on Thursday, August 7, ... results for the second quarter ended June 30, 2014 ... Call Details The second quarter conference call ...
(Date:7/29/2014)... New high priced hepatitis C drugs will increase federal ... to $5.8 billion next year, according to a new ... the Pharmaceutical Care Management Association (PCMA). Milliman projects that ... as 8.6 percent in 2015 as a result of ... The study finds that the majority of new ...
(Date:7/29/2014)... and NEW YORK , ... of the executive management team of Caremark Rx, ... Media ( www.pbm365.com ).  PBM365 is the leading independent ... reporting, insight, analysis and opinion on the pharmacy ... will provide insightful and timely coverage of, and context ...
Breaking Medicine Technology:EnteroMedics to Host Second Quarter 2014 Financial Results and Business Update Conference Call 2EnteroMedics to Host Second Quarter 2014 Financial Results and Business Update Conference Call 3New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015 2Drew Crawford Announces Launch of PBM365 Media 2
... PALM BEACH, Fla., Dec. 15, 2011  China Nuvo Solar ... has recently conducted its first mobile product fair demonstration ... products.  The product fair was recently held and the ... and the Third-Party Consulting Company that has been contracted ...
... 2011  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) ... to its development pipeline, ISIS-APOARx, ISIS-DGAT2Rx and ISIS-FVIIRx.  Isis ... 12:00 p.m. Eastern Time to provide more detail on ... been an extremely successful year for Isis and positions ...
Cached Medicine Technology:China Nuvo Solar Energy, Inc./SurgLine Announces New Mobile Marketing Campaign 2Isis Adds Three New Drugs to Its Development Pipeline 2Isis Adds Three New Drugs to Its Development Pipeline 3Isis Adds Three New Drugs to Its Development Pipeline 4Isis Adds Three New Drugs to Its Development Pipeline 5
(Date:7/29/2014)... 29, 2014 As the Ebola outbreak in ... partners to both purchase critical emergency supplies locally, as well ... Liberia. These supplies will contain materials used to control the ... populated areas of the country. , With a large ... response to the Ebola outbreak in the region. The current ...
(Date:7/29/2014)... July 29, 2014 The Board of Governors ... & Hart LLP ’s Connie Akridge to serve ... serves as President of the Foundation. Akridge served as President ... is a partner at Holland & Hart in Las Vegas, ... regulatory/administrative matters to insurance and healthcare clients for more than ...
(Date:7/29/2014)... NJ (PRWEB) July 29, 2014 ... leading pediatricians have joined our network, CarePoint Health ... and Dr. Sushma Kaki. Hundreds of highly skilled ... a comprehensive network of top doctors and practices ... specialties. This latest acquisition represents CarePoint Health’s commitment ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Tylenol ... individuals who allegedly suffered serious liver injuries due ... move forward in a multidistrict litigation underway in ... Liebhard LLP reports. According to an Order dated ... deadlines pertaining to bellwether case and discovery issues. ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Historically, Memorial ... the United States usually celebrated throughout that time by ... those summer days now mark the start of a ... involving teen drivers. In 2012 nearly 1.000 people ... period from Memorial Day to Labor Day. , The ...
Breaking Medicine News(10 mins):Health News:PCI Responds to Ebola Outbreak in Liberia with Supplies, Awareness Campaigns 2Health News:PCI Responds to Ebola Outbreak in Liberia with Supplies, Awareness Campaigns 3Health News:Holland & Hart LLP Attorney Connie Akridge Reappointed Trustee of the Nevada Bar Foundation 2Health News:Dr. Politis and Dr. Kaki Join CarePoint Health Medical Group 2Health News:Dr. Politis and Dr. Kaki Join CarePoint Health Medical Group 3Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 2Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 3Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 4Health News:Narconon New Life Retreat Launches New Alcohol Prevention Program 2
... 8, 2011) -- Today at the Neglected Tropical Diseases ... in Boston, the Drugs for Neglected Diseases initiative (DNDi) ... new helminth infection drug portfolio to address unmet needs ... project will assess the potential of the drug flubendazole ...
... from a new study revealed that men who smoke had ... who never smoked. Researchers also reported that men who were ... likely to need arthroplasty. Details of this study are now ... Wiley-Blackwell on behalf of the American College of Rheumatology (ACR). ...
... Contrary to popular belief, so-called hypoallergenic dogs do not have ... conclusion of a study by Henry Ford Hospital researchers who ... allergen in the home than other dogs. Hypoallergenic dogs are ... fur. The findings are to be published online this ...
... "A debt ceiling agreement must be reached in time to ... patients who rely on Medicare, Medicaid and other federal health ... American College of Physicians (ACP) told the president, vice president ... our views on enactment of legislation to increase the debt ...
... that could stop the growth of glioblastoma, a deadly form ... journal Cell , a Cell Press publication, a new ... allows them to grow and seed tumors. Importantly, normal stem ... that same dependency. "When thinking about therapeutics [targeting cancer ...
... 2011Companies that try to increase sales of their products ... imply that they support breast cancer researcha practice called ... chemicals shown to cause cancer are committing a form ... article in Environmental Justice, a peer-reviewed journal ...
Cached Medicine News:Health News:DNDi expands activities to neglected patient needs in the field of helminth infections 2Health News:DNDi expands activities to neglected patient needs in the field of helminth infections 3Health News:Male smokers less likely to need joint replacement surgery of hip or knee 2Health News:Study: Hypoallergenic dogs not less allergic than other dogs 2Health News:Debt ceiling agreement 'essential' to prevent disruption of care for Medicare & Medicaid patients 2Health News:Debt ceiling agreement 'essential' to prevent disruption of care for Medicare & Medicaid patients 3Health News:To combat deadly brain cancer, target the stem cells 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: